These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 3436096)

  • 21. [Familial immune deficit and genetic deficiency of adenosine deaminase or of nucleoside phosphorylase (author's transl)].
    Gajdos A
    Nouv Presse Med; 1978 Mar; 7(11):929-34. PubMed ID: 306093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Severe combined immunodeficiency with adenosine deaminase deficiency (author's transl)].
    Allepuz Llop N; Pellejá Pellejá J
    An Esp Pediatr; 1982 May; 16(5):421-5. PubMed ID: 7114620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
    Sawami H; Toyokawa Y; Ito K; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):721-9. PubMed ID: 2618547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 25. Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy.
    Hutton JJ; Wiginton DA; Coleman MS; Fuller SA; Limouze S; Lampkin BC
    J Clin Invest; 1981 Aug; 68(2):413-21. PubMed ID: 7263861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
    Hirschhorn R; Yang DR; Insel RA; Ballow M
    Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe combined immunodeficiency in a child with a healthy adenosine deaminase deficient mother.
    Schmalstieg FC; Mills GC; Tsuda H; Goldman AS
    Pediatr Res; 1983 Dec; 17(12):935-40. PubMed ID: 6606796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adenosine deaminase deficit in severe combined immunodeficiency (author's transl)].
    Español Borén T; Jacques Castro G; Torán Fuentes N; Vives-Corrons JL
    Sangre (Barc); 1981; 26(6):1129-38. PubMed ID: 6805082
    [No Abstract]   [Full Text] [Related]  

  • 29. Prenatal detection of a probable heterozygote for ADA deficiency and severe combined immunodeficiency disease using a microradioassay.
    Aitken DA; Kleijer WJ; Niermeijer MF; Herbschleb-Voogt E; Galjaard H
    Clin Genet; 1980 Apr; 17(4):293-8. PubMed ID: 7371221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 31. Purine metabolism in adenosine deaminase deficiency.
    Mills GC; Schmalstieg FC; Trimmer KB; Goldman AS; Goldblum RM
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2867-71. PubMed ID: 1066699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Family study on the kindred of an adenosine deaminase deficient child with severe combined immunodeficiency.
    Lee CH; Ziegler JB; Rozenberg MC
    Aust N Z J Med; 1979 Oct; 9(5):530-3. PubMed ID: 294907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
    Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
    J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine deaminase deficiency without immunodeficiency: clinical and metabolic studies.
    Borkowsky W; Gershon AA; Shenkman L; Hirschhorn R
    Pediatr Res; 1980 Jul; 14(7):885-9. PubMed ID: 6251420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Polyethylene glycol-adenosine deaminase: a new adenosine deaminase deficiency therapy. Value of deoxyadenosine triphosphate determination for therapeutic monitoring].
    Bory C; Boulieu R; Souillet G; Hershfield MS
    Therapie; 1991; 46(4):323-6. PubMed ID: 1948809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.
    Bax BE; Bain MD; Fairbanks LD; Webster AD; Ind PW; Hershfield MS; Chalmers RA
    Eur J Haematol; 2007 Oct; 79(4):338-48. PubMed ID: 17680812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adenosine deaminase deficiency and severe combined immunodeficiency].
    Ueland PM
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):274-6. PubMed ID: 7385150
    [No Abstract]   [Full Text] [Related]  

  • 38. Radioimmunochemical quantitation of human adenosine deaminase.
    Daddona PE; Frohman MA; Kelley WN
    J Clin Invest; 1979 Sep; 64(3):798-803. PubMed ID: 468994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular pathology of immunological deficiency. Apropos of adenosine deaminase deficiency and nucleoside phosphorylase deficiency].
    Souillet G
    Pediatrie; 1975; 30(7):746-56. PubMed ID: 1105387
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD; Ip H; Pereira S
    Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.